The store will not work correctly when cookies are disabled.
[11C-carbonyl]-3-(4,5-Dihydrooxazol-2-yl)phenyl Hexylcarbamate
ID: ALA2314123
PubChem CID: 136240959
Max Phase: Preclinical
Molecular Formula: C16H22N2O4
Molecular Weight: 306.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCN[11C](=O)Oc1ccc(O)c(C2=NCCO2)c1
Standard InChI: InChI=1S/C16H22N2O4/c1-2-3-4-5-8-18-16(20)22-12-6-7-14(19)13(11-12)15-17-9-10-21-15/h6-7,11,19H,2-5,8-10H2,1H3,(H,18,20)/i16-1
Standard InChI Key: XKJZXQHXTCVWGW-GKTGUEEDSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
8.2443 -18.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2431 -18.9105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9580 -19.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6744 -18.9100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6715 -18.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9562 -17.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3895 -19.3214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5298 -17.6708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5296 -16.8458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8150 -16.4335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2439 -16.4332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8148 -15.6085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -15.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5290 -14.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2433 -13.9582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2431 -13.1332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9575 -12.7205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3385 -17.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1253 -17.8358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6044 -17.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1138 -16.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3315 -16.7627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
1 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 2 0
5 18 1 0
M ISO 1 9 11
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.36 | Molecular Weight (Monoisotopic): 306.1580 | AlogP: 2.84 | #Rotatable Bonds: 7 |
Polar Surface Area: 80.15 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.30 | CX Basic pKa: 2.92 | CX LogP: 3.87 | CX LogD: 3.86 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.76 | Np Likeness Score: -0.08 |
References
1. Wilson AA, Hicks JW, Sadovski O, Parkes J, Tong J, Houle S, Fowler CJ, Vasdev N.. (2013) Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography., 56 (1): [PMID:23214511] [10.1021/jm301492y] |